Syringe device with a dose limiting mechanism and an additional safety mechanism

Information

  • Patent Grant
  • 11097063
  • Patent Number
    11,097,063
  • Date Filed
    Thursday, January 17, 2019
    5 years ago
  • Date Issued
    Tuesday, August 24, 2021
    2 years ago
Abstract
A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.
Description
FIELD OF THE INVENTION

The present invention relates to a syringe device comprising a mechanism for preventing ejection of a dose exceeding a set dose. In particular the present invention relates to a syringe device comprising two independent mechanisms for preventing ejection of a dose exceeding a set dose.


BACKGROUND OF THE INVENTION

When drugs are to be injected into the human body, it may have serious or even lethal consequences if the injected dose exceeds the set dose. Accordingly, it is important that the syringe devices comprises means for limiting ejection to the set dose.


It is an object of the present invention to provide a syringe device comprising means for prevention ejection of a dose exceeding the set dose. Furthermore, as such means may fail, it is an object of the present invention to provide a syringe device comprising a safety mechanism adapted to prevent ejection of a dose exceeding the set dose if the means for preventing fails.


SUMMARY OF THE INVENTION

The present invention relates to a syringe device for ejecting a dose of a medicament, the syringe device comprising:

    • a housing,
    • a dose ejecting mechanism comprising:
      • a dose setting member being rotatable in relation to the housing so as to set a dose to be ejected,
      • a piston rod arranged with respect to the housing such that translational movement of the piston rod in a distal direction causes the dose to be ejected,
      • means for transforming translational movement of the dose setting member into translational movement of the piston rod,
    • a dose limiting mechanism arranged to interact with the dose ejecting mechanism to prevent ejection of a dose exceeding the set dose, and
    • a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.


An advantage of the present invention is that if a dose limiting mechanism fails to limit the ejected dose, the security mechanism is activated, and, thus, provides an extra safety for the patient.


In one embodiment the dose limiting mechanism and the safety mechanism are two independent mechanisms working independently from each other.


In one embodiment the two mechanisms are adapted to simultaneously prevent ejection of a dose exceeding the set dose. In another embodiment the safety mechanism is only activated if the dose limiting mechanism fails to prevent ejection of a dose exceeding the set dose. In one embodiment the two mechanisms are arranged such that even if the dose limiting mechanism fails, the safety mechanism is activated instantaneously such that the ejected dose does not exceed the set dose. In another embodiment the ejected dose is insignificantly larger than the set dose, if the dose limiting mechanism fails and the safety mechanism is activated. By insignificantly larger is meant that the change in dose is too small to have serious or fatal consequences.


The housing may define a passage for the piston rod, the passage may have a threaded inner surface for engagement with a threaded outer surface of the piston rod, the piston rod may be arranged with respect to the housing such that rotation of the piston rod relative to the housing causes the piston rod to be displaced translationally relative to the housing.


In one embodiment at least one of the dose limiting mechanism and the safety mechanism is adapted to limit relative rotational movement between the piston rod and the housing, to a rotation corresponding to ejection of the set dose. This may be the case, when the piston rod comprises a threaded outer surface adapted to engage a threaded inner surface of the housing. Accordingly, rotational locking of the piston rod (relative to the housing) results in a translational locking of the piston rod relative to the housing.


The dose limiting mechanism may comprise at least one first stopping surface adapted to engage at least one corresponding second stopping surface of the housing. Furthermore, rotation of the dose setting member during dose setting may cause the first stopping surface to move away from the second stopping surface and rotation during dose ejection may cause the first and the second surface(s) to move towards each other. Furthermore, ejection of a dose may be prevented when the first stopping surface abut the second stopping surface. The dose setting member may comprise the at least one first stopping surface. Alternatively, or as a supplement, the dose setting member may be coupled to a cylinder comprising a first stopping surface, and said cylinder may be adapted to indicate the set dose. The first and second stopping surfaces may be substantially plane surfaces which may extend in a direction parallel with the axial direction of the syringe device. Alternatively, the stopping surfaces may extend in a plane transverse to the axial direction, such as a plane orthogonal to the axial direction.


In one embodiment the safety mechanism comprises: a limiter defining a passage for the piston rod, the passage of the limiter defining a threaded inner surface for engagement with the threaded outer surface of the piston rod, and a driver defining a passage for the limiter, the driver being rotationally retained in relation to the limiter, the driver being coupled to the dose setting member such that rotation of the dose setting member during dose setting causes the driver to rotate, wherein relative rotation between the drive and the piston rod during dose setting causes the limiter to move away from a stopping position wherein the limiter prevents ejection of a dose.


In one embodiment the syringe device is adapted to prevent setting of a dose which exceeds the amount of a medicament in a reservoir of the syringe device. In such embodiments, the piston rod may comprise an end-of-dose stopping surface adapted engage a corresponding surface of the limiter, when the set dose corresponds to the amount of the medicament in the reservoir of the device. Accordingly, in such embodiments the limiter serves two functions, a first function being prevention of setting of a dose exceeding the amount of the medicament left in the reservoir and a second function being a security function adapted to prevent ejection of a dose exceeding the set dose.


Moreover, the syringe device may comprise an ejection assisting system for providing an ejection force for assisting an operator of the device in forcing the piston in said distal direction so as to eject the set dose. The ejection assisting system may be adapted to force the piston in the distal direction so as to eject the dose, without the aid of the user, when the user has initiated the ejection.


The ejection assisting system may comprise a spring, such as a torsional spring which is arranged to rotate the driver relative to the housing. The spring may be pre-strained when limiter is in the stopping position. Especially when the spring is pre-strained, the redundant security system of the present invention is advantageous, as accidental un-straining of the pre-strained spring, may cause the piston rod to rotate (and thus move translationally) corresponding to a lethal dose, such as 100 IU of insulin.





DESCRIPTION OF THE DRAWINGS

The invention will now be described in further detail with reference to FIG. 1, which discloses a syringe device according to the present invention.






FIG. 1 shows a syringe device 2 comprising a housing 4 and a piston rod 6. The syringe device 2 also comprises a dose setting member 8 and a driver 10, which in the FIGURE are combined into one single unit. The syringe device further comprises a scale drum 12 for indicating a set dose through a window 14. The scale drum 12 has a threaded outer surface 15 adapted to engage a corresponding threaded inner surface 16 of the housing. The scale drum 12 is rotationally retained relative to the driver 10 through a grove-tongue engagement 18. The drum scale 12 comprises a first stopping surface 17 adapted to engage a second stopping surface 19 of the housing. The first stopping surface 17 and the second stopping surface 19 constitutes the dose limiting mechanism 21. The first stopping surface is moved away from the second stopping surface 19 during dose setting and towards each other during dose ejecting. When the two surfaces abut each other, the device is prevented from ejecting the medicament.



FIG. 1 further shows an example of a dose setting member 8 rotatable and longitudinally fixed in relation to the housing 4 so as to set a dose to be injected.


The syringe device comprises an ejection assisting system in the form of a pre-strained torsional spring 23 extending between the driver 10 and a proximal part 20 of the housing. Accordingly, when the dose setting member 8 is rotated to set a dose, the spring is strained even further.


The piston rod 6 comprises a threaded outer surface 22 adapted to engage a corresponding threaded inner surface of the housing 24 and accordingly rotation of the piston rod relative to the housing causes the piston rod to move translationally in relation to the housing. The threaded outer surface 22 of the piston rod also engages a threaded inner surface 26 of a limiter 28, which in FIG. 1 is positioned in a stopping position wherein a bottom surface 30 of the limiter engages an upper surface 32 of a piston rod guide 34. The bottom surface 30 and the upper surface 32 constitute the safety mechanism 31. An air gap may be provided between the bottom surface 30 and the upper surface 32 which allows the limiter and the piston rod to rotate an angel corresponding an insignificant increase in the injected dose e.g. 3 IU of insulin, if the dose limiting mechanism 21 fails during dose injection.


Moreover, an upper end-of-content surface 36 of the limiter 28 is adapted to engage a lower end-of-content surface 38 of a T-shaped end part 40 of the piston rod. The end-of-content surfaces are adapted to engage, when the set dose corresponds to the amount of a medicament remaining in a reservoir (not shown) of the device. Accordingly, the engagement of the end-of-content surfaces prevents setting of a dose exceeding the amount of a medicament remaining in the reservoir. It will be appreciated that the distance between the end-of-content surfaces thus corresponds to the amount of the medicament remaining in the reservoir.


Moreover, an upper surface 11 of the drum 12 may be adapted to engage a lower surface 13 of the housing, when the maximum dose is set. The maximum dose is the largest dose which may be set for each ejection (provided that the syringe device comprises the required amount of medicament). The maximum dose does not correspond to the end-of-content dose which relates the remaining amount of a medicament in the device. Accordingly, as long as the remaining amount of medicament in the device is larger than the maximum dose, the end-of-content surfaces will not abut each other during dose setting, whereas when the remaining amount of medicament in the device is lower than the maximum dose, the maximum dose surfaces will not abut each other during dose setting, as the end-of-content surfaces prevents further rotation.


The limiter 28 and the driver 10 are locked for relative rotation by means of grove-tongue engagement 42. Thus, when the piston rod is locked for rotation relative to the housing, a relative rotation between the driver 8 and the piston rod 6 causes the limiter to move away from the stopping position and towards the t-shaped end part 40 (i.e. upwards in the FIGURE). The piston rod is locked for rotation relative to the housing when the piston rod guide 34 is locked for rotation relative to the housing (not shown), as the piston rod guide 34 and the piston rod are locked for relative rotation due to the grove-tongue engagement 44.


The driver 12 and the piston rod guide 34 are interconnected by a two-way ratchet mechanism 46 comprising at least one first retaining member 48 defined by the driver 12 and at least one second retaining member 50 defined by the piston rod guide 34. The two-way ratchet mechanism is adapted to allow relative rotational movement between the driver 12 and the piston rod guide 34 during dose setting and to ensure that rotational movement of the driver during dose ejection is transferred to the piston rod guide 34.


The use of the device is as follows. Initially the piston rod guide is locked for rotation relative to the housing. Then the dose setting member is rotated, which causes the driver and the drum scale to rotate and the pre-strained spring to be strained even further. At the same time the limiter moves towards the T-shaped end part. If the user tries to set a dose exceeding the amount of medicament in the device, the limiter abuts the T-shaped end part whereby an even larger dose cannot be set. The dose is ejected by removing the rotational lock between the piston rod guide 34 and the housing whereby the strained spring forces the driver to rotate. The rotating driver forces the piston rod guide to rotate which again forces the piston rod to rotate. Due to the grove-tongue engagement 44 and the threaded interconnection between the piston rod and the housing, the rotating piston rod is forced to move forward and thus the medicament is expelled from the device.

Claims
  • 1. A syringe device for ejecting a dose of a medicament, the syringe device comprising: a housing;a dose ejecting mechanism comprising: a dose setting member rotatable in relation to the housing so as to set a dose to be ejected,a piston rod arranged with respect to the housing such that axial movement of the piston rod in a distal direction causes the set dose to be ejected,structure for transforming rotational movement of the dose setting member into axial movement of the piston rod during ejection of the set dose in the form of an ejection assisting system comprising a pre-strained torsional spring arranged to rotate a driver relative to the housing, the pre-strained torsional spring providing an ejection force forcing the piston rod in the distal direction so as to eject the set dose without the aid of a user, when the user has initiated the injection of the set dose;a dose limiting mechanism operably connected with the dose ejecting mechanism to prevent ejection of a dose exceeding the set dose, wherein the dose limiting mechanism comprises a first stopping surface adapted to engage a corresponding second stopping surface of the housing, and wherein rotation of the dose setting member during dose setting causes the first stopping surface to move away from the second stopping surface and wherein ejection of a dose is prevented when the first stopping surface abuts the second stopping surface; anda safety mechanism structure operably connected to the dose ejecting mechanism such that if the dose limiting mechanism fails, the safety mechanism structure prevents ejection of a dose exceeding the set dose.
  • 2. A syringe device according to claim 1, wherein the housing defines a passage for the piston rod, the passage having a threaded inner surface for engagement with a threaded outer surface of the piston rod, the piston rod being arranged with respect to the housing such that rotation of the piston rod relative to the housing causes the piston rod to be displaced axially relative to the housing.
  • 3. A syringe device according to claim 1, wherein at least one of the dose limiting mechanism and the safety mechanism structure is adapted to limit relative rotational movement between the piston rod and the housing, to a rotation corresponding to ejection of the set dose.
  • 4. A syringe device according to claim 1, wherein the dose setting member comprises the first stopping surface.
  • 5. A syringe device according to claim 1, wherein the dose setting member is coupled to a cylinder comprising the first stopping surface, said cylinder being adapted to indicate the set dose.
  • 6. A syringe device according to claim 1, wherein the safety mechanism structure comprises: a limiter defining a passage for the piston rod, the passage of the limiter defining a threaded inner surface for engagement with a threaded outer surface of the piston rod; andthe driver defining a passage for the limiter, the driver being rotationally retained in relation to the limiter, the driver being coupled to the dose setting member such that rotation of the dose setting member during dose setting causes the driver to rotate;wherein relative rotation between the driver and the piston rod during dose setting causes the limiter to move away from a stopping position wherein the limiter prevents ejection of a dose exceeding the set dose.
  • 7. A syringe device according to claim 1, wherein the torsional spring is prestrained when the dose limiting mechanism is in a stopping position.
Priority Claims (1)
Number Date Country Kind
05016286 Jul 2005 EP regional
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of U.S. application Ser. No. 11/996,397, filed Mar. 20, 2008, which is a 35 U.S.C. § 371 national stage application of International Patent Application PCT/EP2006/007006 (published as WO 2007/017053), filed Jul. 17, 2006, which claimed priority of European Patent Application 05016286.6, filed Jul. 27, 2005; this application further claims priority under 35 U.S.C. § 119 of U.S. Provisional Application 60/708,211, filed Aug. 15, 2005. The contents of all above-named applications are incorporated herein by reference.

US Referenced Citations (43)
Number Name Date Kind
4498904 Turner et al. Feb 1985 A
4865591 Sams Sep 1989 A
4883472 Michel Nov 1989 A
5104380 Holman et al. Apr 1992 A
5626566 Petersen et al. May 1997 A
5921966 Bendek et al. Jul 1999 A
5938642 Burroughs et al. Aug 1999 A
6221046 Burroughs et al. Apr 2001 B1
6221053 Walters et al. Apr 2001 B1
6235004 Steenfeldt-Jensen et al. May 2001 B1
6248095 Giambattista et al. Jun 2001 B1
6569123 Alchas et al. May 2003 B2
6582404 Klitgaard et al. Jun 2003 B1
6585698 Packman et al. Jul 2003 B1
6663602 Moller Dec 2003 B2
6699224 Kirchhofer et al. Mar 2004 B2
6899699 Enggaard May 2005 B2
7104972 Moller et al. Sep 2006 B2
7112187 Karlsson Sep 2006 B2
7169132 Bendek et al. Jan 2007 B2
7195616 Diller et al. Mar 2007 B2
7309327 Kirchhofer et al. Dec 2007 B2
7500966 Hommann Mar 2009 B2
7553299 Veasey et al. Jun 2009 B2
7686786 Moller et al. Mar 2010 B2
7811263 Burren et al. Oct 2010 B2
7828779 Kirchhofer et al. Nov 2010 B2
8096978 Markussen Jan 2012 B2
8357120 Moller Jan 2013 B2
8444606 Radmer et al. May 2013 B2
8721601 Burren et al. May 2014 B2
8920383 Enggaard et al. Dec 2014 B2
9775953 Enggaard et al. Oct 2017 B2
10220155 Eiland Mar 2019 B2
20020120235 Enggaard Aug 2002 A1
20020165500 Bechtold et al. Nov 2002 A1
20050033224 Kirchhofer et al. Feb 2005 A1
20050033244 Veasey Feb 2005 A1
20050261634 Karlsson Nov 2005 A1
20060270985 Hommann et al. Nov 2006 A1
20080208142 Moller Aug 2008 A1
20080221530 Glejbol et al. Sep 2008 A1
20150080812 Enggaard et al. Mar 2015 A1
Foreign Referenced Citations (35)
Number Date Country
20209051 Apr 2003 DE
69810860 Nov 2003 DE
10229122 Feb 2004 DE
10351596 Jun 2005 DE
897728 Feb 1999 EP
897729 Feb 1999 EP
0937471 Aug 1999 EP
937476 Aug 1999 EP
5016291.6 Jul 2005 EP
1909870 Apr 2008 EP
2002-503116 Jan 2002 JP
2005-508205 Mar 2005 JP
2091087 Sep 1997 RU
2212254 Sep 2003 RU
1528330 Dec 1989 SU
8702895 May 1987 WO
1996027400 Sep 1996 WO
2006114395 Aug 1999 WO
9938554 Aug 1999 WO
0119434 Mar 2001 WO
0195959 Dec 2001 WO
02053214 Jul 2002 WO
2002092153 Nov 2002 WO
03011374 Feb 2003 WO
2004007003 Jan 2004 WO
2004028598 Apr 2004 WO
2004030730 Apr 2004 WO
04078240 Sep 2004 WO
2005018721 Mar 2005 WO
2006045526 May 2006 WO
06058883 Jun 2006 WO
2006076921 Jul 2006 WO
06089768 Aug 2006 WO
06125328 Nov 2006 WO
06125329 Nov 2006 WO
Non-Patent Literature Citations (12)
Entry
Non-Final Office Action issued by the PTO for U.S. Appl. No. 11/996,397 dated Dec. 31, 2008.
Non-Final Office Action issued by the PTO for U.S. Appl. No. 11/996,397 dated Aug. 25, 2009.
Final Rejection in U.S. Appl. No. 11/996,397, filed January 1, 2008 by Eiland et al. dated Apr. 20, 2010.
Statement by Dr. Nils Basso printed May 8, 2010.
Description of the Mechanical Components of the OPTICLIK Pen printed May 8, 2010.
Ypsomed Ag Press Release Jan. 16, 2005 (German and English versions).
Anlage E23 Eidesstattliche Versichemng Herr Peter Ryser.
Anlage E24 Eidesstattliche Versicherung Herr Nicolas Binggeli.
Anlage E25 Eidesstattliche Versichemng Frau Daniela Moser.
Offenkundige Vorbenutzung Durch Die Injektionsvorrichtung “Flexpen” E20a-c.
Anlage E26 (Fig. 10).
Notice of Opposition in EP1909870 dated Dec. 12, 2011.
Related Publications (1)
Number Date Country
20190192783 A1 Jun 2019 US
Provisional Applications (1)
Number Date Country
60708211 Aug 2005 US
Continuations (1)
Number Date Country
Parent 11996397 US
Child 16250620 US